Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens

Blood

Volumn 93, Issue 7, 1999, Pages 2336-2341

  Mutis, Tuna ^a   Verdijk, Rob ^a   Schrama, Ellen ^a   Esendam, Bennie ^a   Brand, Anneke ^a   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; SYNTHETIC PEPTIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEASIBILITY STUDY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; LEUKEMIA; MINOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE ACTIVATION;

EID: 0033120425     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2336.407k26_2336_2341     Document Type: Article

References (26)

1. O'Reilly RJ: Allogeneic bone marrow transplantation: Current status and future directions. Blood 62:941, 1983
2. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
3. Ringden O, Sundberg B, Lonnqvist B, Tollemar J, Gahrton G, Nilsson B: Allogeneic bone marrow transplantation for leukemia: Factors of importance for long-term survival and relapse. Bone Marrow Transplant 3:281, 1988
4. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
5. Kolb HJ, Holler E: Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 9:139, 1997
6. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermuller J, de Witte T, Holler E, Ansari H: Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86:2041, 1995
7. Gratwohl A, Hermans J, Apperley JF, Arcese W, Bacigalupo A, Bandini G, di-Bartolomeo P, Boogaerts M, Bosi A, Carreras E, Devergie A, Ferrant A, Fibbe WE, Frassoni F, Gahrton G, Goldman JM, Iriondo A, Jacobsen N, Kolb HJ, Link H, Michallet M, Prentice HG, Reiffers J, van Rhee F, Ruutu T, Schwaighofer H, Vernant JP, de Witte T, Niederwieser D: Acute graft-versus-host disease: Grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 86:813, 1995
8. Goulmy E: Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157:125, 1997
9. van der Harst D, Goulmy E, Falkenburg JHF, Kooij-Winkelaar YM, van Luxemburg-Heijs SA, Goselink HM, Brand A: Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83:1060, 1994
10. Niederwieser D, Grassegger A, Aubock J, Herold M, Nachbaur D, Rosenmayr A, Gachter A, Nussbaumer W, Gaggl S, Ritter M, Huber C: Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81:2200, 1993
11. Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JHF: Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest 96:877, 1995
12. Falkenburg JHF, Goselink HM, vander Harst D, van Luxemburg-Heijs SA, Kooy-Winkelaar YM, Faber LM, de Kroon J, Brand A, Fibbe WE, Willemze R, Goulmy E: Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med 174:27, 1991
13. de Bueger M, Bakker A, van Rood JJ, Van der Woude F, Goulmy E: Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-denned non-MHC antigens. J Immunol 149:1788, 1992
14. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E: Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476, 1995
15. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, Reinhardus C, Shabanowitz J, Offringa R, Hunt DF, Engelhard VH, Goulmy E:The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 279:1054, 1998
16. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1988
17. Mehta-Damani A, Markowicz S, Engleman EG: Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 153:996, 1994
18. Dupuis M, Peshwa MV, Benike C, Kundu SK, Engleman EG, van Schooten WCA, Merigan TC: Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals. AIDS Res Hum Retroviruses 13:33, 1997
19. Gagliardi MC, De Petrillo G, Salemi S, Boffa L, Longobardi MG, Dellabona P, Casorati G, Tanigaki N, Harris R, Lanzavecchia A, Barnaba V: Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int Immunol 7:1741, 1995
20. Ostankowitch M, Le Gal F-A, Connan F, Chassin D, Choppin J, Guillet J-G: Generation of Melan-A/Mart-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: Helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro. Int J Cancer 72:987, 1997
21. van Lochem E, van der Keur M, Mommaas AM, de Gast GC, Goulmy E: Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells. Transplant Immunol 4:151, 1996
22. van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI: Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur J Immunol 26:1683, 1996
23. Tsai V, Southwood S, Sidney J., Sakaguchi K, Kawakami Y, Apella E, Sette A, Celis E. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J Immunol 158:1796, 1997
24. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JHF, Vossen J, Grathwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ: Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334:281, 1996
25. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C: HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719, 1997
26. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med 2:551, 1996